Hepion Pharmaceuticals's total assets for Q3 2025 were $3.74M, a decrease of -16.98% from the previous quarter. HEPA total liabilities were $415.81K for the fiscal quarter, a -41.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.